BioDuro: Exploring Cutting-Edge Tech for More Reliable Formulations
The development of enhanced drug formulations requires an in-depth, data-driven understanding of Active Pharmaceutical Ingredients’ (APIs) physicochemical properties and their behavior in vivo. At BioDuro, formulation challenges such as poor solubility, stability, and bioavailability are addressed by systematically analyzing key characteristics of the API and the target patient population, explains Dr. Yuan Yang, Senior Scientist III, Formulation Development, BioDuro. A scientific approach that balances the inherent risk of formulation complexity with the practical needs of the drug product is critical for success.